BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 36869400)

  • 1. Current advances in understanding the molecular profile of hereditary diffuse gastric cancer and its clinical implications.
    Lim HJ; Zhuang L; Fitzgerald RC
    J Exp Clin Cancer Res; 2023 Mar; 42(1):57. PubMed ID: 36869400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDH1 and hereditary diffuse gastric cancer: a narrative review.
    Gregory SN; Davis JL
    Chin Clin Oncol; 2023 Jun; 12(3):25. PubMed ID: 37303221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).
    Lo W; Zhu B; Sabesan A; Wu HH; Powers A; Sorber RA; Ravichandran S; Chen I; McDuffie LA; Quadri HS; Beane JD; Calzone K; Miettinen MM; Hewitt SM; Koh C; Heller T; Wacholder S; Rudloff U
    J Med Genet; 2019 Jun; 56(6):370-379. PubMed ID: 30745422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
    Chen I; Mathews-Greiner L; Li D; Abisoye-Ogunniyan A; Ray S; Bian Y; Shukla V; Zhang X; Guha R; Thomas C; Gryder B; Zacharia A; Beane JD; Ravichandran S; Ferrer M; Rudloff U
    J Transl Med; 2017 May; 15(1):92. PubMed ID: 28460635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer predisposition and germline CTNNA1 variants.
    Lobo S; Benusiglio PR; Coulet F; Boussemart L; Golmard L; Spier I; Hüneburg R; Aretz S; Colas C; Oliveira C
    Eur J Med Genet; 2021 Oct; 64(10):104316. PubMed ID: 34425242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of c.1531C>T Pathogenic Variant in the
    Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.
    Obermair F; Rammer M; Burghofer J; Malli T; Schossig A; Wimmer K; Kranewitter W; Mayrbaeurl B; Duba HC; Webersinke G
    Fam Cancer; 2019 Apr; 18(2):253-260. PubMed ID: 30306390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview on new progress of hereditary diffuse gastric cancer with
    Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
    Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk.
    Gamble LA; Rossi A; Fasaye GA; Kesserwan C; Hernandez JM; Blakely AM; Davis JL
    JAMA Surg; 2022 Jan; 157(1):18-22. PubMed ID: 34643667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
    Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
    de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.
    Seevaratnam R; Coburn N; Cardoso R; Dixon M; Bocicariu A; Helyer L
    Gastric Cancer; 2012 Sep; 15 Suppl 1():S153-63. PubMed ID: 22160243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
    Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
    Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined loss of CDH1 and downstream regulatory sequences drive early-onset diffuse gastric cancer and increase penetrance of hereditary diffuse gastric cancer.
    São José C; Garcia-Pelaez J; Ferreira M; Arrieta O; André A; Martins N; Solís S; Martínez-Benítez B; Ordóñez-Sánchez ML; Rodríguez-Torres M; Sommer AK; Te Paske IBAW; Caldas C; Tischkowitz M; Tusié MT; ; Hoogerbrugge N; Demidov G; de Voer RM; Laurie S; Oliveira C
    Gastric Cancer; 2023 Sep; 26(5):653-666. PubMed ID: 37249750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
    Garcia-Pelaez J; Barbosa-Matos R; Lobo S; Dias A; Garrido L; Castedo S; Sousa S; Pinheiro H; Sousa L; Monteiro R; Maqueda JJ; Fernandes S; Carneiro F; Pinto N; Lemos C; Pinto C; Teixeira MR; Aretz S; Bajalica-Lagercrantz S; Balmaña J; Blatnik A; Benusiglio PR; Blanluet M; Bours V; Brems H; Brunet J; Calistri D; Capellá G; Carrera S; Colas C; Dahan K; de Putter R; Desseignés C; Domínguez-Garrido E; Egas C; Evans DG; Feret D; Fewings E; Fitzgerald RC; Coulet F; Garcia-Barcina M; Genuardi M; Golmard L; Hackmann K; Hanson H; Holinski-Feder E; Hüneburg R; Krajc M; Lagerstedt-Robinson K; Lázaro C; Ligtenberg MJL; Martínez-Bouzas C; Merino S; Michils G; Novaković S; Patiño-García A; Ranzani GN; Schröck E; Silva I; Silveira C; Soto JL; Spier I; Steinke-Lange V; Tedaldi G; Tejada MI; Woodward ER; Tischkowitz M; Hoogerbrugge N; Oliveira C
    Lancet Oncol; 2023 Jan; 24(1):91-106. PubMed ID: 36436516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment.
    Luo W; Fedda F; Lynch P; Tan D
    Front Pharmacol; 2018; 9():1421. PubMed ID: 30568591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome.
    Molinaro V; Pensotti V; Marabelli M; Feroce I; Barile M; Pozzi S; Laghi L; Serrano D; Bernard L; Bonanni B; Ranzani GN
    Genes Chromosomes Cancer; 2014 May; 53(5):432-45. PubMed ID: 24493355
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.